Park Place Capital Corp »

Crinetics Pharmaceuticals In shares owned by Park Place Capital Corp

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Park Place Capital Corp from 13F filings

Historical chart of Park Place Capital Corp investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Park Place Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Park Place Capital Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $842 18 46.83

More positions owned by Park Place Capital Corp

Ishares Core S&p 500 Etf Etf (IVV)
Microsoft Corp Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares S&p 500 Growth Etf Etf (IVW)
Aptus Defined Risk Etf Etf (DRSK)
Ishares S&p 500 Value Etf Etf (IVE)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Apple Stock (AAPL)
Ishares Mbs Etf Etf (MBB)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon Stock (AMZN)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)

View all positions for Park Place Capital Corp

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Lord, Abbett & Co
Ikarian Capital
Goldman Sachs Group

View all funds holding Crinetics Pharmaceuticals In